Toxicity associated with stavudine dose reduction from 40 to 30 mg in first-line antiretroviral therapy.

<h4>Background</h4>To compare the incidence and timing of toxicity associated with the use of a reduced dose of stavudine from 40 to 30 mg in first-line antiretroviral therapy (ART) for HIV treatment and to investigate associated risk factors.<h4>Methods</h4>Multicohort study...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mar Pujades-Rodríguez, Emmanuelle Dantony, Loretxu Pinoges, René Ecochard, Jean-François Etard, Esther Carrillo-Casas, Elisabeth Szumilin, AIDS Working Group of Médecins Sans Frontières
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/55981807dc624f34a168e91a1d0f1a79
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!